Related Experiment Videos
Immunological abnormalities in splenic marginal zone cell lymphoma
H Murakami1, H Irisawa, T Saitoh
1Gunma University Hospital, Maebashi, Japan.
American Journal of Hematology
|November 26, 1997
Summary
Splenic marginal zone cell lymphoma (SMZCL) can present with significant immunological and hematological abnormalities. These include autoimmune hemolytic anemia and immune thrombocytopenia, which may indicate lymphoma activity.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Clinical features of splenic marginal zone cell lymphoma (SMZCL) are infrequently documented.
- Understanding SMZCL's presentation is crucial for patient management and prognosis.
Observation:
- This study details immunological and hematological abnormalities in three SMZCL patients.
- Observed abnormalities included autoimmune hemolytic anemia, immune thrombocytopenia, and lupus anticoagulant in two patients.
Findings:
- Monoclonal gammopathy and cold agglutinin were also noted in two of the three patients.
- Immunological abnormalities appear to be characteristic complications of SMZCL.
Implications:
- These immunological findings may serve as reliable markers for monitoring SMZCL activity.
- Careful monitoring of immunological status is recommended for patients diagnosed with SMZCL.